These stability studies seek to determine that the device is biocompatible with the drug for a two year shelf life. Stability studies are more a regulatory process than a risk for us, as all materials within the fluid path being USP class six compliant (biocompatible) and currently used in other approved devices such as standard prefilled syringes.
- Forums
- ASX - By Stock
- UNS
- production commence end of q1
production commence end of q1, page-20
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)